Form 4 for CRVS Corvus Pharmaceuticals, Inc.

Accepted 2022-03-17 00:00:00 ET · period of report 2022-03-16 · accession 0001567619-22-007173 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2022-03-17	2022-03-16+	CRVS	LEA LEIV	CFO	P - Purchase	$1.57	+49.0K	85.4K	+135%	+$77.0K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-17	P	A	13,878	$1.65	99,238	I By IRA	—	—	(F3) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.62 to $1.66 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F2) These shares are held by Leiv Lea IRA Contributory.
2	Common	Common Stock	2022-03-16	P	A	35,160	$1.54	85,360	I By IRA	—	—	(F1) The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.45 to $1.60 inclusive. Upon request, the Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the SEC full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. (F2) These shares are held by Leiv Lea IRA Contributory.